Size: px
Start display at page:

Download ""

Transcription

1 Page 1 of 5 Home > Research & Grants > Research and Scientific Programs > What is genetic testing for breast cancer and who should get it? What is genetic testing for breast cancer and who should get it? Most breast cancers are not related to genes or family history. In fact, only five to 10 percent of all breast cancers diagnosed in the U.S. are thought to be hereditary. 1-3 However, if you have been diagnosed with breast cancer, you may worry about the risk to your family members. And, if a family member has been diagnosed, you may worry about your own risk. So, who really needs to be concerned about this and who should consider genetic testing? Furthermore, if you do have a breast cancer gene mutation or a strong family history, what can you do to lower your risk of developing breast cancer? Talking to your health care provider is the best way to understand your (or your family s) risk of hereditary breast cancer. Here, we cover the basics of hereditary breast cancer and genetic testing to help you discuss these topics with your provider. Genes and gene mutations Every cell in your body contains genes. Genes contain the blueprints (genetic code) for your body. For example, they contain the information that determines the color of your eyes. They also contain information that affects the functions of your body, such as when cells grow, divide and die. The information in your genes is passed on (inherited) from both your mother and your father. And, you can pass this information on to your children. Some changes in the genetic code that affect the function of the gene are called mutations. Mutations can be passed on from a parent to a child. Many of these inherited gene mutations have little or no effect on health (good or bad). Others, however, can increase the risk of certain diseases, including cancer. Mutations in certain genes are known to increase breast cancer risk. A family history of some cancers is also important. Having multiple immediate family members with breast or ovarian cancer can increase breast cancer risk, even when no known genetic mutation has been identified in the family. Learn more about having a family history of breast (or ovarian) cancer and breast cancer risk. Inherited gene mutations and breast cancer risk BRCA1 and BRCA2 (BReast CAncer genes 1 and 2) are the best-known genes linked to breast cancer risk. There are other less common genes that also increase risk and still others that are under study (learn more). How many people in the U.S. have BRCA1 or BRCA2 gene mutations? BRCA1 and BRCA2 mutations are rare in the general U.S. population (about 1 in 400 people have one of these mutations). However, they are more common among certain ethnic groups. For example, among Ashkenazi (Eastern European) Jewish men and women, about one in 40 people has a BRCA1 or BRCA2 mutation. 2 Learn more about ethnicity and the prevalence of BRCA1 and BRCA2 mutations. BRCA1 and BRCA2 gene mutations and female breast cancer Women in the general U.S. population have about an eight percent chance of developing breast cancer by age Women who have a BRCA1 gene mutation, however, have a 50 to 70 percent chance of developing breast cancer by age 70. For women who have a BRCA2 mutation, estimates of risk range from 40 to 60 percent by age This means in a group of 100 women in the general population, about eight will develop breast cancer by age 70. While in a group of 100 women with a BRCA1 or BRCA2 mutation, between 40 and 70 will develop breast cancer by age 70. (These numbers are averages, so the risk for an individual may fall

2 Page 2 of 5 outside this range.) Although women who have a BRCA1 or BRCA2 mutation have a greatly increased risk of breast cancer compared to those who do not, their risk of breast cancer is not 100 percent. Some women with a mutation will never get breast cancer. 4 And, women without a mutation are still at risk (most women who develop breast cancer do not have a BRCA1 or BRCA2 mutation). For those who do have a BRCA1 or BRCA2 mutation, there are steps that can lower risk and special screening guidelines to help ensure that if breast cancer does develop, it is caught early. Learn more about risk-lowering options for women who have a BRCA1 or BRCA2 mutation. BRCA1 and BRCA2 gene mutations and male breast cancer BRCA2 mutations (and possibly BRCA1 mutations) also increase the risk of male breast cancer. 2,5-7 In the general U.S. population, about 1 in 1,000 men will develop breast cancer in their lifetime. Among men with a BRCA2 mutation however, about 65 in 1,000 will develop breast cancer. 8-9 Although only five to 10 percent of female breast cancers are thought to be due to gene mutations, up to 40 percent of male breast cancers may be related to BRCA2 mutations. 10 This means that men who develop breast cancer are more likely than women who develop breast cancer to have an inherited gene mutation. Who should consider genetic testing for BRCA1 and BRCA2 mutations? Genetic testing gives people the chance to learn if their breast cancer or their family history of breast cancer is due to an inherited gene mutation. Breast cancer is common and BRCA1 and BRCA2 mutations are rare, so just having a close relative with breast cancer does not mean that a BRCA1 or BRCA2 mutation is present in the family. However, the more relatives with breast or ovarian cancer and the younger their ages at the time of their cancer diagnosis you have, the higher the chance that your family has a BRCA1 or BRCA2 (or other gene) mutation. Genetic testing is recommended only for certain people, including those with: 11 A family member (parent, sibling, child, grandparent, grandchild, uncle, aunt, nephew, niece or first cousin) diagnosed with breast cancer at age 45 or younger A family member (parent, sibling, child, grandparent, grandchild, uncle, aunt, nephew, niece or first cousin) diagnosed with ovarian cancer at any age A personal or family history of both breast and ovarian cancers on the same side of the family A personal or family history of male breast cancer Ashkenazi Jewish heritage (as well as a family history of breast or ovarian cancer) A personal history of breast cancer at age 45 or younger A personal or family history of bilateral breast cancer (cancer in both breasts) A health care provider or genetic counselor can help you decide whether genetic testing is appropriate for you or your family members. Many insurance providers cover the costs of at least a large part of the testing when it is medically recommended. In most cases, testing is first done on the person with breast cancer. If no mutation is found in that person, the cancer was probably not due to a BRCA1 or BRCA2 genetic mutation and other family members do not need to be tested. If a mutation is found, other family members can be tested for the specific BRCA1 or BRCA2 mutation found in the person with breast cancer. It is not likely that all family members will have the mutation. For example, if your mother has a BRCA1 or BRCA2 mutation, there is only a 50 percent chance you also have a mutation (you get half of your genes from your mother and half from your father). If no one in your family who has had breast cancer or ovarian cancer is available for testing (or if your family medical history is unknown), your provider or a genetic counselor can help you decide whether genetic testing would be informative for you. He/she can also help you decide whether testing for genes other than BRCA1 and BRCA2 might be appropriate for you. Benefits and risks of genetic testing Although a simple blood test is all that is needed to check for a BRCA1 or BRCA2 mutation, the benefits and risks should be considered before testing. There are potential physical, emotional and financial impacts of knowing your genetic status. Your provider or a genetic counselor can discuss these issues with you.

3 Page 3 of 5 Benefits You and your health care provider can better personalize your breast care plan. This may include being screened at a younger age and more often. You can also take steps (such as risk-lowering drugs or preventive surgery) to lower your risk of breast cancer. You can take steps to lower your risk of ovarian cancer. You may be able to join a clinical trial of risk-lowering options for people with BRCA1 and BRCA2 mutations. Or if you have been recently diagnosed (or recently had a recurrence), you may be able to join a clinical trial of treatment for people with BRCA1 and BRCA2 mutations. BreastCancerTrials.org in collaboration with Susan G. Komen for the Cure offers a custom matching service that can help you find a clinical trial recruiting people with BRCA1, BRCA2 or other genetic mutations. Learn more about clinical trials. Risks For some people, knowing they have a BRCA1 or BRCA2 mutation can cause worry and anxiety, even though they may never get breast cancer. They may also worry about an increased breast cancer risk for their siblings and children (and the anxiety it may cause those family members). For others, knowing they do not have a mutation may give a false sense of security of not being at risk for breast cancer, and as a result may not get routine breast cancer screening. (All women should get routine breast cancer screening to lower their risk of dying from breast cancer.) Although there are laws to help protect against genetic discrimination, there are some limits. The Genetic Information Nondiscrimination Act (GINA) prevents health insurers from denying coverage or charging higher premiums if your genetic profile puts you at higher risk for breast cancer. It also protects against genetic discrimination from employers. However, GINA does not prevent life insurance providers or disability insurance providers from denying coverage. At-home genetic testing You may have seen ads for at-home genetic testing kits. These kits are not recommended for assessing breast cancer risk. The U.S. Food and Drug Administration, U.S. Federal Trade Commission and Centers for Disease Control and Prevention all caution against the use of at-home testing kits. The results of any genetic test should be interpreted by a trained health care provider or genetic counselor Conclusions Although only about five to 10 percent of breast cancers in the U.S. are thought to be hereditary, for people who have a BRCA1 or BRCA2 gene mutation, the risk of breast cancer is greatly increased. Most women, even most breast cancer survivors, have only a small chance of having a BRCA1 or BRCA2 gene mutation. Those who test negative for a mutation still have a risk of breast cancer based on other factors (learn more). If you are considering genetic testing, it is important to talk to your health care provider or a genetic counselor. These trained medical professionals can help you determine whether testing for BRCA1 and/or BRCA2 mutations is appropriate for you. Komen s role in research on hereditary breast cancer Susan G. Komen for the Cure s Research and Scientific Programs provide support for research from the roles BRCA1 and BRCA2 genes play in the development of cancer to designing treatments specific to BRCA1 and BRCA2 related breast cancers. Dr. Judy Garber, MD, MPH, Director of the Cancer Risk and Prevention Clinic at Dana-Farber Cancer Institute and Komen Scholar offers a nice take home message from all of the information presented in this article. It has been more than 15 years since the BRCA1 and BRCA2 genes were identified. In that time, women have fought to make genetic information available to those who would use the information to try to reduce the risks of breast and ovarian cancers, in particular, for themselves and their family members. Ongoing research has

4 Page 4 of 5 helped to: 1) provide better estimates of breast and ovarian cancer risk in people with BRCA1 and BRCA2 mutations 2) identify better breast cancer screening strategies for people with BRCA1 and BRCA2 mutations 3) identify strategies to lower the risk of breast and ovarian cancers in women with BRCA1 or BRCA2 mutations 4) explore more effective ways to treat BRCA-related breast cancers 5) ensure genetic testing is conducted responsibly with appropriate counseling for patients and family members" None of this research would be possible without the dedication of people who participate in these clinical trials. On behalf of her fellow researchers Dr. Garber added, We thank our patients for their commitment to this research, all over the world." Komen has invested more than $24 million in research focused on BRCA1/2 genes through our various grant mechanisms, including a Promise Grant focused on breast cancer prevention in people who have BRCA1 or BRCA2 mutations. Learn more about the research we are funding. Learn more about Komen s research on BRCA1/2 and hereditary breast cancer. References 1. American Cancer Society. Cancer Facts & Figures American Cancer Society, National Cancer Institute. Genetics of breast and ovarian cancer (PDQ) American Cancer Society. Breast Cancer Facts & Figures , Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 25(11): , Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 336: , Antoniou AC, Cunningham AP, Peto J, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 98(8): , Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 367(9510): , Isaacs C, Peshkin BN, Schwartz M. Chapter 19: Genetic Testing and Management of Patients with Hereditary Breast Cancer, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition, Lippincott Williams & Wilkins, Liede A, Karlan BY, Narod SA. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol. 22(4):735-42, Thorlacius S, Sigurdsson S, Bjarnadottir H, et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet. 60(5): , National Comprehensive Cancer Network. NCCN Clinical practices guidelines in oncology: Breast cancer risk reduction. V U.S. Food and Drug Administration. Cracking down on health fraud U.S. Federal Trade Commission. Facts for consumers At-home genetic tests: a healthy dose of skepticism may be the best prescription Centers for Disease Control and Prevention. Genomic testing.

5 Page 5 of Posted September 27, 2012

Does Cancer Run in Your Family?

Does Cancer Run in Your Family? Does Cancer Run in Your Family? Nancie Petrucelli, MS, CGC Clinical Assistant Professor Certified Genetic Counselor/Coordinator Cancer Genetic Counseling Service Karmanos Cancer Institute Wayne State University

More information

patient education Fact Sheet

patient education Fact Sheet patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations OCTOBER 2017 BRCA1 and BRCA2 Mutations Cancer is caused by several different factors. A few types of cancer run in families. These types are

More information

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer

More information

Does Cancer Run in Your Family?

Does Cancer Run in Your Family? Does Cancer Run in Your Family? A Patient s Guide to Hereditary Breast and Ovarian Cancer Syndrome What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that

More information

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer. to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer testing is right for you and should be reviewed with a trained healthcare

More information

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor Cancer Survivorship Symposium Cancer and Heredity January 16, 2017 Jeanne P. Homer, MS Licensed Certified Genetic Counselor Outline Cancer and Heredity Hereditary Cancer Risk Assessment & Genetic testing

More information

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent. Welcome. My name is Amanda Brandt. I am one of the Cancer Genetic Counselors at the University of Texas MD Anderson Cancer Center. Today, we are going to be discussing how to identify patients at high

More information

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide The benefit of knowing Genetic testing for hereditary cancer A patient support guide Does cancer run in your family? Cancer is more common in some families. Sometimes cancer is caused by a change in a

More information

BRCAnowTM It s Your Decision

BRCAnowTM It s Your Decision Hereditary Breast and Ovarian Cancer BRCAnowTM It s Your Decision Patient & Physician Information What is BRCA? The breast cancer genes BRCA1 and BRCA2 are found within an individual s normal genetic makeup;

More information

WELCOME. Taking Care of Your Health. April 30, 8 am to noon

WELCOME. Taking Care of Your Health. April 30, 8 am to noon WELCOME Taking Care of Your Health April 30, 8 am to noon Cancer: Know Your Risk Emily Kuchinsky, MS, CGC, Certified Genetic Counselor Sporadic Cancer Lifetime Probability- Women Family Cluster Risk factors

More information

Importance of Family History in Gynecologic Cancer Prevention. Objectives. Genetic Counselors. Angela Thompson, MS, CGC

Importance of Family History in Gynecologic Cancer Prevention. Objectives. Genetic Counselors. Angela Thompson, MS, CGC Importance of Family History in Gynecologic Cancer Prevention Angela Thompson, MS, CGC Genetic Counselor Froedtert & The Medical College of Wisconsin Objectives Introduce role of genetic counselor Discuss

More information

Precision Medicine and Genetic Counseling : Is Yes always the correct answer?

Precision Medicine and Genetic Counseling : Is Yes always the correct answer? Precision Medicine and Genetic Counseling : Is Yes always the correct answer? Beverly M. Yashar, MS, PhD, CGC Director, Graduate Program in Genetic Counseling Professor, Department of Human Genetics. (yashar@umich.edu)

More information

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond.

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond. HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond. Conni Murphy, ARNP Cancer Risk Assessment and Genetics Program Jupiter Medical Center Learning Objectives Identify

More information

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information GeneticsNow TM A Guide to Testing Hereditary Conditions in Women & Men Patient & Physician Information How can BRCA status affect your health? Everyone has BRCA1 and BRCA2 genes. However, sometimes the

More information

Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women

Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women Background About 5% of women in Canada with breast cancer and about 12% of women with ovarian cancer, are born with an inherited

More information

Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer

Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_breast_and_ovarian_cancer 8/1997 8/2017

More information

Utilization of BRCA Testing. Breast and Ovarian Cancer in Texas

Utilization of BRCA Testing. Breast and Ovarian Cancer in Texas Utilization of BRCA Testing in Older Ode Women with Breast and Ovarian Cancer in Texas Ana M. Rodriguez, MD Assistant Professor Department of Obstetrics and Gynecology University of Texas Medical Branch

More information

A Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You?

A Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You? A Patient s Guide to Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You? What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that cancer.

More information

BRCA2 gene. Associated Syndrome Name: Hereditary Breast and Ovarian Cancer syndrome (HBOC) BRCA2 Summary Cancer Risk Table. BRCA2 gene Overview

BRCA2 gene. Associated Syndrome Name: Hereditary Breast and Ovarian Cancer syndrome (HBOC) BRCA2 Summary Cancer Risk Table. BRCA2 gene Overview BRCA gene Associated Syndrome Name: Hereditary Breast and Cancer syndrome (HBOC) BRCA Summary Cancer Risk Table Male Breast GENETIC RISK Female Breast Elevated Risk Elevated Risk BRCA gene Overview Hereditary

More information

Genetic Testing for BRCA1 and BRCA2 Genes

Genetic Testing for BRCA1 and BRCA2 Genes Genetic Testing for BRCA1 and BRCA2 Genes MP9478 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below Pre and post-test genetic counseling

More information

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc)

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc) patient guide BRCA1 and BRCA2 genetic testing for hereditary breast and ovarian cancer (hboc) Because knowing your risk can mean early detection and prevention Know the Basics People with HBOC may have

More information

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes. Hello. My name is Maureen Mork and I m a Certified Genetic Counselor in the Clinical Cancer Genetics Program at The University of Texas MD Anderson Cancer Center. I ll be lecturing today on the Cancer

More information

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 15, 1997 October 9, 2013

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 15, 1997 October 9, 2013 Medical Policy Genetic Testing for Hereditary Breast and/or Ovarian Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date:

More information

FACULTY RESOURCE CASE GUIDE CASE: JEFF

FACULTY RESOURCE CASE GUIDE CASE: JEFF FACULTY RESOURCE CASE GUIDE CASE: JEFF CASE DESCRIPTION: Career military male, age 41, whose father was diagnosed with breast cancer several years ago. Father had genetic testing and found to harbor a

More information

Eligibility criteria for prophylactic treatment allowance

Eligibility criteria for prophylactic treatment allowance Eligibility criteria for prophylactic treatment allowance Southern Cross will only pay the prophylactic treatment allowance for the following healthcare services when the applicable eligibility criteria

More information

BRCA Precertification Information Request Form

BRCA Precertification Information Request Form BRCA Precertification Information Request Form Failure to complete this form in its entirety may result in the delay of review. Fax to: BRCA Precertification Department Fax number: 1-860-975-9126 Section

More information

Policy and Procedure. Department: Utilization Management. SNP, CHP, MetroPlus Gold, Goldcare I&II, Market Plus, Essential, HARP

Policy and Procedure. Department: Utilization Management. SNP, CHP, MetroPlus Gold, Goldcare I&II, Market Plus, Essential, HARP Retired Date: Page 1 of 9 1. POLICY DESCRIPTION: BRCA 1&2 Genetic Testing 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management, Pharmacy, Claim

More information

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing. Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing. Hereditary cancer and you Approximately 5% to 10% of all cancers develop because a person inherited a genetic

More information

GENETIC MANAGEMENT OF A FAMILY HISTORY OF BREAST AND / OR OVARIAN CANCER. Dr Abhijit Dixit. Family Health Clinical Genetics

GENETIC MANAGEMENT OF A FAMILY HISTORY OF BREAST AND / OR OVARIAN CANCER. Dr Abhijit Dixit. Family Health Clinical Genetics GENETIC MANAGEMENT OF A FAMILY HISTORY OF BREAST AND / OR OVARIAN CANCER Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review

More information

Genetic Testing for BRCA1 and BRCA2 Genes

Genetic Testing for BRCA1 and BRCA2 Genes Genetic Testing f BRCA1 and BRCA2 Genes MP9478 Covered Service: Pri Authization Required: Additional Infmation: Yes when meets criteria below Yes--as shown below Pre and post-test genetic counseling is

More information

I have ovarian cancer

I have ovarian cancer I have ovarian cancer Everything you need to know about BRCA1/2 gene mutations (NHS England only) 1 An introduction to BRCA1/2 gene mutations BRCA1 and BRCA2 are genes that repair damage in cells and prevent

More information

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) A Patient s Guide to risk assessment Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer

More information

This information explains the advice about familial breast cancer (breast cancer in the family) that is set out in NICE guideline CG164.

This information explains the advice about familial breast cancer (breast cancer in the family) that is set out in NICE guideline CG164. Familial breast cancer (breast cancer in the family) Information for the public Published: 1 June 2013 nice.org.uk About this information NICE guidelines provide advice on the care and support that should

More information

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention Know the Basics Breast cancer is the most common cancer in women

More information

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011 Medical Policy Manual Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer Date of Origin: January 27, 2011 Section: Genetic Testing Last Reviewed Date: July 2014 Policy No: 02 Effective

More information

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations patient guide TumorNext-HR D a test for ovarian cancer patients to identify hereditary and tumor-specific mutations Because knowing can mean personalized treatment and management Germline vs. Tumor Testing

More information

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) A Patient s Guide to risk assessment Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer

More information

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) A Patient s Guide to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary

More information

GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER BRCA1 BRCA2

GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER BRCA1 BRCA2 GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER BRCA1 BRCA2 Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER SYNDROME BRCA1 BRCA2

GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER SYNDROME BRCA1 BRCA2 SYNDROME BRCA1 BRCA2 Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) A Patient s Guide to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary

More information

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations patient guide TumorNext-HR D a test for ovarian cancer patients to identify hereditary and tumor-specific mutations Because knowing can mean personalized treatment and management Germline vs. Tumor Testing

More information

The benefit of knowing

The benefit of knowing The benefit of knowing Genetic testing for familial hypercholesterolemia (FH) A patient support guide 2 Does high cholesterol run in your family? In some families, high cholesterol is caused by familial

More information

Genetic Screening Visit

Genetic Screening Visit Before your visit In a typical hereditary breast ovarian cancer genetic counsling visit be prepared to answer the following set of questions, please check were applicable. About your self (same questions

More information

Commonly asked questions about genetic testing for hereditary cancer

Commonly asked questions about genetic testing for hereditary cancer Commonly asked questions about genetic testing for hereditary cancer Understanding genetic testing for hereditary cancer What is hereditary cancer? In some cases, cancer is caused by genetic changes (or

More information

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention Know the Basics The average age of diagnosis for melanoma is 63 YEARS

More information

Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families

Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families What is Hereditary Breast and Ovarian Cancer (HBOC)? Hereditary Breast and Ovarian Cancer is a genetic condition which

More information

Know your past, protect your future.

Know your past, protect your future. Why do you need a Medical Family Tree? Your medical family tree records your family's health history, and can help you make informed decisions for health. In the course of creating your medical family

More information

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian ANNOUNCER OPEN: Welcome to CME on ReachMD. This segment, entitled Inherited Susceptibility to Cancer: What Do Primary Care Providers

More information

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center Disclosure- I DO NOT HAVE any relevant financial interest with any entity producing,

More information

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious Understanding Your Genetic Test Result Positive for a Deleterious Mutation or Suspected Deleterious This workbook is designed to help you understand the results of your genetic test and is best reviewed

More information

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania Aging Family history Early menarche Late menopause Nulliparity Estrogen / Progesterone use after menopause More than two alcoholic

More information

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY BRCA 1/2 Breast cancer testing THINK ABOUT TOMORROW, TODAY 5 10% of patients with breast and/or ovarian cancer have a hereditary form1. For any individual carrying a mutation in BRCA1 or BRCA2, the lifetime

More information

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG Hereditary Breast and Ovarian Cancer 2015 Rebecca Sutphen, MD, FACMG Among a consecutive series of 11,159 women requesting BRCA testing over one year, 3874 responded to a mailed survey. Most respondents

More information

Applies to: All Aetna plans, except Traditional Choice plans. All Innovation Health plans, except indemnity plans

Applies to: All Aetna plans, except Traditional Choice plans. All Innovation Health plans, except indemnity plans BRCA Precertification Information Request Form Applies to: All Aetna plans, except Traditional Choice plans All Innovation Health plans, except indemnity plans All Health benefits and health insurance

More information

Getting to Know the Generation Program s Approach to Disclosing Information about Your Risk for Alzheimer s disease

Getting to Know the Generation Program s Approach to Disclosing Information about Your Risk for Alzheimer s disease Getting to Know the Generation Program s Approach to Disclosing Information about Your Risk for Alzheimer s disease The Generation Program is made up of two clinical trials: Generation Study 1 and Generation

More information

Cancer Conversations

Cancer Conversations Cancer Conversations Announcer: Welcome to Cancer Conversations, a podcast series from Dana-Farber Cancer Institute. In this Episode from July 2014, Dr. Huma Rana, Clinical Director of Dana-Farber s Center

More information

Why Test for Hereditary Cancer in Preventive Care?

Why Test for Hereditary Cancer in Preventive Care? Why Test for Hereditary Cancer in Preventive Care? Millions of people are sidelined by cancer. Wouldn't it be worth it for your patients to know their risk? background HEREDITARY (5-10%) More than 1 in

More information

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center Definitions: DNA: The material found in our cells - the instructions

More information

BRCA genes and inherited breast and ovarian cancer. Information for patients

BRCA genes and inherited breast and ovarian cancer. Information for patients BRCA genes and inherited breast and ovarian cancer Information for patients This booklet has been written for people who have a personal or family history of breast and/or ovarian cancer that could be

More information

Advice about familial aspects of breast cancer and epithelial ovarian cancer

Advice about familial aspects of breast cancer and epithelial ovarian cancer Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals FEBRUARY 2006 These guidelines contain three parts: 1. Information for health professionals

More information

PROVIDER POLICIES & PROCEDURES

PROVIDER POLICIES & PROCEDURES PROVIDER POLICIES & PROCEDURES BRCA GENETIC TESTING The purpose of this document is to assist providers enrolled in the Connecticut Medical Assistance Program (CMAP) with the information needed to support

More information

DFCI IRB RECOMMENDED CONSENT LANGUAGE RELATING TO RETURN OF RESEARCH RESULTS

DFCI IRB RECOMMENDED CONSENT LANGUAGE RELATING TO RETURN OF RESEARCH RESULTS Consent Language Office for Human Research Studies DANA-FARBER / HARVARD CANCER CENTER DFCI IRB RECOMMENDED CONSENT LANGUAGE RELATING TO RETURN OF RESEARCH RESULTS This Information Sheet provides investigators

More information

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-09 Effective Date: 03/17/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members

More information

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious Understanding Your Genetic Test Result Positive for a Deleterious Mutation or Suspected Deleterious This workbook is designed to help you understand the results of your genetic test and is best reviewed

More information

We know that treatments are now targeting genes, but does genetics play a bigger role in cancer outside of that?

We know that treatments are now targeting genes, but does genetics play a bigger role in cancer outside of that? Welcome to the 3Ps of Cancer podcast, where we'll discuss prevention, preparedness, and progress in cancer treatments and research. Brought to you by the University of Michigan Rogel Cancer Center. I'm

More information

Lori Carpenter, MS, LCGC Saint Francis Hospital

Lori Carpenter, MS, LCGC Saint Francis Hospital Lori Carpenter, MS, LCGC Saint Francis Hospital What is cancer genetic counseling Myth 1: Breast cancer is inevitable in my family Myth 2: My family history is on my dad s side, so it doesn t count Myth

More information

GRANT SUBMISSION Northern Sunrise County. Submitted to: Peter Thomas, CAO

GRANT SUBMISSION Northern Sunrise County. Submitted to: Peter Thomas, CAO GRANT SUBMISSION Northern Sunrise County Submitted to: Peter Thomas, CAO January 2016 Contents 1. PROJECT OVERVIEW... 1 2. ABOUT THE CAUSE... 1 2.1. What is HBOC syndrome?... 1 2.1. What can be done?...

More information

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention Know the Basics Risk factors for developing pancreatic cancer

More information

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017 Genetics 101 Hereditary Breast and Ovarian Cancer 2017 Rebecca Sutphen, MD, FACMG Professor, College of Medicine President & Chief Medical Officer INVASIVE CANCER GENETICALLY ALTERED CELL HYPERPLASIA DYSPLASIA

More information

Please read the following instructions carefully

Please read the following instructions carefully Grand River Regional Cancer Centre 835 King Street West, PO Box 9056 Kitchener, ON N2G 1G3 Tel: (519) 749-4370 x2832 Fax: (519) 749-4394 Dear: You have been referred to the High Risk Ontario Breast Screening

More information

Accuracy of the BRCAPRO Model Among Women With Bilateral Breast Cancer

Accuracy of the BRCAPRO Model Among Women With Bilateral Breast Cancer Accuracy of the BRCAPRO Model Among Women With Bilateral Breast Cancer Kaylene J. Ready, MS 1, Kristen J. Vogel, MS 2, Deann P. Atchley, PhD 1, Kristine R. Broglio, MS 1, Kimberly K. Solomon, MBA 1, Christopher

More information

patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention

patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention Some of the most common cancers diagnosed are: Know the Basics breast prostate uterine

More information

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention Know the Basics Prostate cancer is the most common cancer in

More information

Examining Racial Differences in Utilization of Genetic Counseling Services in Hereditary Cancer Network Database

Examining Racial Differences in Utilization of Genetic Counseling Services in Hereditary Cancer Network Database Examining Racial Differences in Utilization of Genetic Counseling Services in Hereditary Cancer Network Database Taylor Seaton, MS Cancer Genomics Epidemiologist MDHHS Cancer Genomics Program: Lifecourse

More information

Hereditary Gynecologic Cancer

Hereditary Gynecologic Cancer patient guide Hereditary Gynecologic Cancer genetic testing panels Because knowing your risk can mean early detection and prevention About half of the women diagnosed with uterine (endometrial) cancer

More information

Updates in Cancer Genetics & Genomics

Updates in Cancer Genetics & Genomics Updates in Cancer Genetics & Genomics Jennifer R. Klemp, PhD, MPH, MA Associate Professor of Medicine, Division of Clinical Oncology Director, Cancer Survivorship Co-Program Leader, Cancer Prevention and

More information

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You? A Patient s Guide to Hereditary Cancer Is Hereditary Cancer Testing Right for You? What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that cancer. This is

More information

Genetic Determinants, Risk Assessment and Management

Genetic Determinants, Risk Assessment and Management Genetic Determinants, Risk Assessment and Management Rachel Rando, MS, CGC Genetic Counselor Hunterdon Regional Cancer Center Flemington, NJ I have no disclosures. Acknowledgements: Staff of Hunterdon

More information

Reference #: SYS-PC-VPCI-CG-002. Origination Date: June 2012 Next Review Date: April 2019 Effective Date: April 2016

Reference #: SYS-PC-VPCI-CG-002. Origination Date: June 2012 Next Review Date: April 2019 Effective Date: April 2016 Oncology Service Line-Allina Health System-wide Consensus Guidelines: Identification of Breast Cancer Patients at Risk for Inherited Cancer Risks These guidelines apply to clinical interventions that have

More information

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR HEREDITARY BRCA MUTATIONS. POLICY NUMBER: CATEGORY: Laboratory Test

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR HEREDITARY BRCA MUTATIONS. POLICY NUMBER: CATEGORY: Laboratory Test MEDICAL POLICY SUBJECT: GENETIC TESTING FOR HEREDITARY BRCA MUTATIONS POLICY NUMBER: 2.02.06 CATEGORY: Laboratory Test EFFECTIVE DATE: 01/17/02 REVISED DATE: 08/21/03, 09/16/04, 08/18/05, 06/15/06, 04/17/14,

More information

Hereditary Breast and Ovarian Cancer Screening & Genetic Counseling

Hereditary Breast and Ovarian Cancer Screening & Genetic Counseling Hereditary Breast and Ovarian Cancer Screening & Genetic Counseling Cecelia Bellcross, PhD, MS, CGC Emory University School of Medicine Department of Human Genetics The First Line of Defense February 21,

More information

Approximately 5% to 10% of breast cancer (BC) is hereditary in nature. Since. By Dawna Gilchrist, MD, FRCPC, FCCMG

Approximately 5% to 10% of breast cancer (BC) is hereditary in nature. Since. By Dawna Gilchrist, MD, FRCPC, FCCMG By Dawna Gilchrist, MD, FRCPC, FCCMG Approximately 5% to 10% of breast cancer (BC) is hereditary in nature. Since the discovery of the genes BRCA 1 and 2 in the early 1990s, genetic counselling and testing

More information

GENETIC TESTING FOR HEREDITARY CANCER

GENETIC TESTING FOR HEREDITARY CANCER UnitedHealthcare Oxford Clinical Policy GENETIC TESTING FOR HEREDITARY CANCER Policy Number: DIAGNOSTIC 004.27 T2 Effective Date: November 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS

More information

IBMPFD Educational Information For Patients and Families

IBMPFD Educational Information For Patients and Families Page 1 of 5 CLIA # 05D1034314 CA State License: CLF 332383 IBMPFD Educational Information For What is IBMPFD? IBMPFD stands for Inclusion Body Myopathy associated with Paget s disease of bone and/or Frontotemporal

More information

I have ovarian cancer

I have ovarian cancer I have ovarian cancer Everything you need to know about BRCA1/2 gene mutations (Scotland only) 1 An introduction to BRCA1/2 gene mutations BRCA1 and BRCA2 are genes that repair damage in cells and prevent

More information

HBOC. Jessica M. Salamone, ScM, CGC

HBOC. Jessica M. Salamone, ScM, CGC HBOC Jessica M. Salamone, ScM, CGC Certified Genetic Counselor Director of the Cancer Risk Assessment & Genetic Counseling Program Elizabeth Wende Breast Care, LLC Elizabeth Wende Breast Care Internationally

More information

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer patient guide Lynch Syndrome genetic testing for hereditary colorectal and uterine cancer Because knowing your risk can mean early detection and prevention Know the Basics People with Lynch syndrome may

More information

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins. WHAT IS A GENE? CHROMOSOME GENE DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE

More information

Information for You and Your Family

Information for You and Your Family Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the

More information

Are you at risk of Hereditary Cancer? Your Guide to the Answers

Are you at risk of Hereditary Cancer? Your Guide to the Answers Are you at risk of Hereditary Cancer? Your Guide to the Answers What is Hereditary Cancer? The genes we are born with may contribute to our risk of developing certain types of cancer, including breast,

More information

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Shawnia Ryan, MS, LCGC Senior Genetic Counselor University of New Mexico Cancer Center

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Shawnia Ryan, MS, LCGC Senior Genetic Counselor University of New Mexico Cancer Center GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Shawnia Ryan, MS, LCGC Senior Genetic Counselor University of New Mexico Cancer Center What is genetic counseling? communication process address individual

More information

Cancer Genetics Baylor All Saints Medical Center at Fort Worth

Cancer Genetics Baylor All Saints Medical Center at Fort Worth Cancer Genetics Baylor All Saints Medical Center at Fort Worth Thank you for your interest in the Hereditary Cancer Risk Program (HCRP). Please complete the family history and risk factor questionnaire

More information

Susan G. Komen Central and Northern Arizona

Susan G. Komen Central and Northern Arizona Susan G. Komen Central and Northern Arizona Frank Nagy, Mission Director WHY IS EARLY DETECTION IMPORTANT? WHY IS EARLY DETECTION IMPORTANT? Regular screening tests (along with follow-up tests and treatment

More information

About 5% of cases of breast cancer and 10% of cases of ovarian cancer are

About 5% of cases of breast cancer and 10% of cases of ovarian cancer are Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey Lisa S. Di Prospero, * Maureen Seminsky, * Joanne

More information

PATIENT INFORMATION. (Last) (First) (Middle) (Last) (City) (State) (Zip)

PATIENT INFORMATION. (Last) (First) (Middle) (Last) (City) (State) (Zip) PATIENT INFMATION : Address: (Last) (First) (Middle) (Last) (City) (State) (Zip) Home Phone: Cell Phone: Email address: Birth date: : Gender: When is the best time to contact you? May we email you for

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association BRCA1 and BRCA2 Testing Page 1 of 26 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: BRCA1 and BRCA2 Testing Pre-Determination of Services IS REQUIRED by the Member

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association BRCA1 and BRCA2 Testing Page 1 of 33 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: BRCA1 and BRCA2 Testing Pre-Determination of Services IS REQUIRED by the Member

More information

Part III of IV: Precision Medicine and Pharmacogenomics. How cancer genomics is causing a radical shift in cancer research and management

Part III of IV: Precision Medicine and Pharmacogenomics. How cancer genomics is causing a radical shift in cancer research and management Part III of IV: Precision Medicine and Pharmacogenomics How cancer genomics is causing a radical shift in cancer research and management March 2018 Author Shealynn Buck, M.D. Chief Medical Officer Lockton

More information

patient guide Clinical Genomics genetic testing for undiagnosed diseases Taking the extra step to find answers

patient guide Clinical Genomics genetic testing for undiagnosed diseases Taking the extra step to find answers patient guide Clinical Genomics genetic testing for undiagnosed diseases Taking the extra step to find answers Know the Basics You are made up of about 20,000 genes This is called your genome Genomic testing

More information